星輝娛樂(300043.SZ)擬定增募資不超3億元 用於網絡遊戲開發及運營建設項目
格隆匯 8 月 11日丨星輝娛樂(300043.SZ)披露2020年度以簡易程序向特定對象發行股票預案,此次發行擬募集資金總額為3億元,扣除發行費用後擬投資於以下項目:3億元用於網絡遊戲開發及運營建設項目。
此次擬發行股票數量為8982.0359萬股,不超過此次發行前公司總股本的30%,最終發行股票數量以中國證監會關於此次發行的同意註冊文件為準。
此次發行對象不超過35名,均以人民幣現金方式認購,根據股東大會的授權,公司及保薦機構(主承銷商)按照市場化競價情況,遵循價格優先、金額優先、時間優先原則,協商確定此次發行價格為3.34元/股,此次發行對象及其獲配股數、金額具體情況如下:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.